Bio & Pharma
Daewoong, Indonesia's IPB to co-research on primate
It will support the establishment of a primate research center, commercialization of pharmaceuticals and medical devices
By Jun 27, 2024 (Gmt+09:00)
1
Min read
Most Read
LG Chem to sell water filter business to Glenwood PE for $692 million


KT&G eyes overseas M&A after rejecting activist fund's offer


Kyobo Life poised to buy Japan’s SBI Group-owned savings bank


StockX in merger talks with Naver’s online reseller Kream


Meritz backs half of ex-manager’s $210 mn hedge fund



South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it signed a contract with Indonesia's Bogor Agricultural University (Institut Pertanian Bogor, IPB) for joint research on primates.
Daewoong Pharmaceutical will collaborate with IPB to establish a specialized primate research center, commercialize pharmaceuticals and medical devices through primate research, and foster veterinary talent.
The company explained that the specialized primate research center will help secure competitiveness in the preclinical stage by evaluating the toxicity and efficacy of new drug candidates.
The specific cooperation will be carried out through the Center for Primate Studies (Pusat Studi Satwa Primata, PSSP), a research institution under IPB.
Write to Young-ae Lee at 0ae@hankyung.com
More to Read
-
Bio & PharmaDaewoong Pharmaceutical digitizes DB of 800 mn chemical compounds
Feb 19, 2024 (Gmt+09:00)
1 Min read -
Bio & PharmaDaewoong gets stem cell facility license in Indonesia
Feb 13, 2024 (Gmt+09:00)
1 Min read -
Bio & PharmaDaewoong exports $92.4 mn Depot injection tech to UAE
Dec 11, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaDaewoong Pharm set to export Envlo Tab to Russia, CIS
Dec 01, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaDaewoong Pharma, Merck team up for AI tech for new drug
Oct 31, 2023 (Gmt+09:00)
1 Min read
Comment 0
LOG IN